Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.060
+0.090 (2.27%)
At close: Feb 10, 2026, 4:00 PM EST
4.060
0.00 (0.00%)
After-hours: Feb 10, 2026, 4:27 PM EST
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $256.92 million as of February 10, 2026. Its market cap has increased by 363.93% in one year.
Market Cap
256.92M
Enterprise Value
173.41M
1-Year Change
363.93%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has decreased from $677.31M to $256.92M, a decrease of -62.07%. That is a compound annual growth rate of -16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 251.22M | 8.77% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 270.45M |
| Fennec Pharmaceuticals | 268.45M |
| Climb Bio | 266.41M |
| Cellectis | 265.29M |
| Palisade Bio | 256.29M |
| Avalo Therapeutics | 256.22M |
| OmniAb | 251.20M |
| Coherus Oncology | 244.16M |